SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001273087-24-000015
Filing Date
2024-01-16
Accepted
2024-01-16 16:12:48
Documents
1
Group Members
ISRAEL A. ENGLANDERMILLENNIUM GROUP MANAGEMENT LLCMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 INZY_SC13GA1.htm SC 13G/A 79816
  Complete submission text file 0001273087-24-000015.txt   81785
Mailing Address 399 PARK AVENUE NEW YORK NY 10022
Business Address 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
MILLENNIUM MANAGEMENT LLC (Filed by) CIK: 0001273087 (see all company filings)

IRS No.: 133804139 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91586 | Film No.: 24535286
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)